🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Holly Fernandez Lynch

Institute of Medical Ethics

ORCID: 0000-0001-7813-9879

Also affiliated with University of Pennsylvania

MedicineEconomics, Econometrics and FinanceHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “The role of community engagement in addressing bystander risks in research: The case of a Zika virus controlled human infection study”.

The role of community engagement in addressing bystander risks in research: The case of a Zika virus controlled human infection study

Bioethics(2020)10.1111/bioe.12806
N/A
0.425DataRank · unranked
16 citations

F. DeWolfe Miller, Holly Fernandez Lynch, Seema Shah

Minimal or reasonable? Considering the ethical threshold for research risks to nonconsenting bystanders and implications for nonconsenting participants

Bioethics(2020)10.1111/bioe.12725
N/A
0DataRank · unranked
5 citations

Holly Fernandez Lynch

An ethics framework for consolidating and prioritizing COVID-19 clinical trials

Clinical Trials(2021)10.1177/1740774520988669
N/A
0DataRank · unranked
25 citations

Luke Gelinas, Barbara E. Bierer, Sara Chandros Hull, Steven Joffe, David Magnus +7 more

A snapshot of U.S. IRB review of COVID-19 research in the early pandemic

Journal of Clinical and Translational Science(2021)10.1017/cts.2021.848
N/A
0DataRank · unranked
12 citations

Kimberley Serpico, Holly Fernandez Lynch, John C. Baumann, Emily E. Anderson, Holly A. Taylor

How Do Accredited Organizations Evaluate the Quality and Effectiveness of Their Human Research Protection Programs?

AJOB Empirical Bioethics(2022)10.1080/23294515.2022.2090641
N/A
0DataRank · unranked
12 citations

Holly A. Taylor, Holly Fernandez Lynch

Considering tomorrow’s patients in today’s drug approvals

BMJ(2023)10.1136/bmj-2023-075000
N/A
0DataRank · unranked
10 citations

Emily A. Largent, Holly Fernandez Lynch

A Framework for Assessing the Permissibility of Academic Leaders’ Outside Activities

Milbank Quarterly(2025)10.1111/1468-0009.70024
N/A
0DataRank · unranked
1 citations

Martha E. Gaines, Steven Joffe, Genevieve P. Kanter, Emily A. Largent, Bernard Lo +4 more

Prescribing Changes After Accelerated vs Regular Approval of Oncology Therapies

JAMA Network Open(2025)10.1001/jamanetworkopen.2025.20726
N/A
0DataRank · unranked
1 citations

Ernesto Ulloa‐Pérez, Martin J. Kurian, Rebecca A. Hubbard, Steven Joffe, Holly Fernandez Lynch +2 more

Regulatory flexibility for COVID-19 research

Journal of Law and the Biosciences(2020)10.1093/jlb/lsaa057
N/A
0DataRank · unranked
50 citations

Neal W. Dickert, Patricia J. Zettler, Steven Joffe, Emily A. Largent, Holly Fernandez Lynch

Never Waste a Crisis: The Past, Present, and Future of FDA Reform

Journal of Health Politics Policy and Law(2025)10.1215/03616878-12262664
N/A
0DataRank · unranked
0 citations

Reshma Ramachandran, Holly Fernandez Lynch, Patricia J. Zettler